The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Role of Fks1p and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene
Open accessAbstract
Candida infections frequently involve drug-resistant biofilm growth on device surfaces. Glucan synthase gene FKS1 has been linked to triazole resistance in Candida biofilms. We tested the impact of FKS1 modulation on susceptibility to additional antifungal classes. Reduction of FKS1 expression rendered biofilms more susceptible to amphotericin B, anidulafungin, and flucytosine. Increased resistance to anidulafungin and amphotericin B was observed for biofilms overexpressing FKS1 . These findings suggest that Candida biofilm glucan sequestration is a multidrug resistance mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genes involved in production and delivery of β-1,3-glucans include the synthase-encoding gene FKS1 and the genes BGL2, XOG1, and PHR1, which encode proteins involved in the modification and transport of β-glucans (132, 189).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Biofilm Formation: A Clinically Relevant Microbiological Process
Donlan, R. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322972 · Cited by 1,343
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T., Pitts, B., Pellock, B. J., Walker, G. C., Stewart, P. S., & O’Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Biofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Roemer, T., Jiang, B., Davison, J., Ketela, T. W., Veillette, K., Breton, A., Tandia, F., Linteau, A., Sillaots, S., Marta, C., et al. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03697.x · Cited by 513
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511
Cited by
Sorted by citations
The global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Falsetta, M. L., Klein, M. I., Colonne, P. M., Scott-Anne, K., Gregoire, S., Pai, C.-H., González–Begne, M., Watson, G. E., Krysan, D. J., Bowen, W. H., et al. (2014) · Infection and Immunity · doi:10.1128/iai.00087-14 · Cited by 578
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms
Acker, H. V., Dijck, P. V., & Coenye, T. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.02.001 · Cited by 546
Pathogenesis ofCandida albicansbiofilm
Tsui, C., Kong, E. F., & Jabra‐Rizk, M. A. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw018 · Cited by 522
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Self-citationAntifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
Biofilm of Candida albicans : formation, regulation and resistance
Pereira, R., Fontenelle, R. O. D. S., de Brito, É. H. S., & de Morais, S. M. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14949 · Cited by 417
Candida parapsilosis: from genes to the bedside
Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00111-18 · Cited by 327
Novel Entries in a Fungal Biofilm Matrix Encyclopedia
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., et al. (2014) · mBio · doi:10.1128/mbio.01333-14 · Cited by 315
Self-citationCandida Species Biofilms’ Antifungal Resistance
Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 317
Kong, E. F., Tsui, C., Kucharíková, S., Andes, D. R., Dijck, P. V., & Jabra‐Rizk, M. A. (2016) · mBio · doi:10.1128/mbio.01365-16 · Cited by 305
Self-citationA Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
Self-citationCandida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
Current Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Antifungal drug-resistance mechanisms in Candida biofilms
Kaur, J., & Nobile, C. J. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102237 · Cited by 279
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Self-citationHoefs, S., Mogavero, S., & Hube, B. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5514-0 · Cited by 251
Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
Chaabane, F., Graf, A., Jequier, L., & Coste, A. T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02788 · Cited by 223
Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition
Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 222
Reactive Oxygen Species-Inducing Antifungal Agents and Their Activity Against Fungal Biofilms
Delattin, N., Cammue, B. P., & Thevissen, K. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.189 · Cited by 189
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C. P., Appanna, V. D., Singh, R. I., Saunders, D., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 207
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 205
Community participation in biofilm matrix assembly and function
Mitchell, K. F., Zarnowski, R., Sanchez, H., Edward, J. A., Reinicke, E. L., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421437112 · Cited by 183
Self-citationAn expanded regulatory network temporally controls C andida albicans biofilm formation
Fox, E. P., Bui, C. K., Nett, J. E., Hartooni, N., Mui, M. C., Andes, D. R., Nobile, C. J., & Johnson, A. D. (2015) · Molecular Microbiology · doi:10.1111/mmi.13002 · Cited by 173
Self-citationRajendran, R., Williams, C., Lappin, D. F., Millington, O., Martins, M., & Ramage, G. (2013) · Eukaryotic Cell · doi:10.1128/ec.00287-12 · Cited by 173
Update on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 181
Nett, J. E., Sanchez, H., Cain, M. T., Ross, K. M., & Andes, D. R. (2011) · Eukaryotic Cell · doi:10.1128/ec.05126-11 · Cited by 168
Self-citationThe Candida albicans Biofilm Matrix: Composition, Structure and Function
Pierce, C. G., Vila, T. V. M., Romo, J. A., Montelongo‐Jauregui, D., Wall, G., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2017) · Journal of Fungi · doi:10.3390/jof3010014 · Cited by 173
Contributions of the Biofilm Matrix to Candida Pathogenesis
Nett, J. E., & Andes, D. R. (2020) · Journal of Fungi · doi:10.3390/jof6010021 · Cited by 164
Self-citationAzole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity
Rajendran, R., Mowat, E., McCulloch, E., Lappin, D. F., Jones, B., Lang, S., Majithiya, J. B., Warn, P. A., Williams, C., & Ramage, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01189-10 · Cited by 157
Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance
Kowalski, C. H., Morelli, K. A., Schultz, D., Nadell, C. D., & Cramer, R. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003700117 · Cited by 151
Nett, J. E., Cain, M. T., Crawford, K., & Andes, D. R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02273-10 · Cited by 153
Self-citationBonhomme, J., Chauvel, M., Goyard, S., Roux, P., Rossignol, T., & d'Enfert, C. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07626.x · Cited by 144
Aspergillus biofilms: clinical and industrial significance
Ramage, G., Rajendran, R., Gutierrez-Correa, M., Jones, B., & Williams, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02381.x · Cited by 136
Fungal persister cells: The basis for recalcitrant infections?
Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136
Portrait of Candida Species Biofilm Regulatory Network Genes
Araújo, D., Henriques, M., & Silva, S. M. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.004 · Cited by 140
Sherry, L., Rajendran, R., Lappin, D. F., Borghi, E., Perdoni, F., Falleni, M., Tosi, D., Smith, K., Williams, C., Jones, B., et al. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-182 · Cited by 138
Candida auris Infection and Biofilm Formation: Going Beyond the Surface
Horton, M. V., & Nett, J. E. (2020) · Current Clinical Microbiology Reports · doi:10.1007/s40588-020-00143-7 · Cited by 132
Self-citationFungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions
Mitchell, K. F., Zarnowski, R., & Andes, D. R. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005828 · Cited by 132
Self-citationFan, F., Liu, Y., Liu, Y., Lv, R., Sun, W., Ding, W., Cai, Y., Li, W., Liu, X., & Qu, W. (2022) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2022.106673 · Cited by 140
Biofilm formation byAspergillus fumigatus
Kaur, S., & Singh, S. (2013) · Medical Mycology · doi:10.3109/13693786.2013.819592 · Cited by 128
Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00680-13 · Cited by 120
Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
Bonhomme, J., & d’Enfert, C. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.007 · Cited by 120
Molecular basis of antifungal drug resistance in yeasts
Morio, F., Jensen, R. H., Le Pape, P., & Arendrup, M. C. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.012 · Cited by 114
Uppuluri, P., Srinivasan, A., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01701-10 · Cited by 100
Morelli, K. A., Kerkaert, J. D., & Cramer, R. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009794 · Cited by 101
Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges
de Barros, P. P., Rossoni, R. D., de Souza, C. M., Scorzoni, L., Fenley, J. D. C., & Junqueira, J. C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00445-w · Cited by 106
Candida albicans Biofilm Development and Its Genetic Control
Desai, J. V., & Mitchell, A. P. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0005-2014 · Cited by 94
Munro, C. A. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407678-5.00004-0 · Cited by 92
Antifungal Resistance and the Role of New Therapeutic Agents
Logan, A., Wolfe, A. L., & Williamson, J. (2022) · Current Infectious Disease Reports · doi:10.1007/s11908-022-00782-5 · Cited by 101
The Extracellular Matrix of Fungal Biofilms
Mitchell, K. F., Żarnowski, R., & Andes, D. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_6 · Cited by 93
Self-citationVázquez-Muñoz, R., Arellano-Jiménez, M. J., & Lopez-Ribot, J. L. (2020) · BMC Biomedical Engineering · doi:10.1186/s42490-020-00044-2 · Cited by 83
Candida albicans targets that potentially synergize with fluconazole
Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81
Future directions for anti-biofilm therapeutics targetingCandida
Nett, J. E. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885838 · Cited by 80
Self-citationDominguez, E., Zarnowski, R., Sanchez, H., Covelli, A. S., Westler, W. M., Azadi, P., Nett, J., Mitchell, A. P., & Andes, D. R. (2018) · mBio · doi:10.1128/mbio.00451-18 · Cited by 77
Self-citationResistance mechanism and proteins in Aspergillus species against antifungal agents
Shishodia, S. K., Tiwari, S., & Shankar, J. (2019) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2019.1574927 · Cited by 82
Dias, J. D. N., de-Souza-Silva, C. M., de Araújo, A. R., Souza, J. M. T., Júnior, P. H. D. H. V., Cabral, W. F., da Silva, M. D. G., Eaton, P. J., Leite, J. R. S. A., Nicola, A. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67041-2 · Cited by 79
Kucharíková, S., Tournu, H., Holtappels, M., Dijck, P. V., & Lagrou, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00697-10 · Cited by 73
Topological and Mutational Analysis of Saccharomyces cerevisiae Fks1
Johnson, M. E., & Edlind, T. D. (2012) · Eukaryotic Cell · doi:10.1128/ec.00082-12 · Cited by 70
Combination Therapy to Treat Fungal Biofilm-Based Infections
Tits, J., Cammue, B. P. A., & Thevissen, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228873 · Cited by 71
Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs
Romera, D., Aguilera-Correa, J. J., Gadea, I., Viñuela-Sandoval, L., García‐Rodríguez, J., & Esteban, J. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001036 · Cited by 69
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
Eradication of Candida albicans persister cell biofilm by the membranotropic peptide gH625
Galdiero, E., de Alteriis, E., De Natale, A., D’Alterio, A., Siciliano, A., Guida, M., Lombardi, L., Falanga, A., & Galdiero, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62746-w · Cited by 65
Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens
Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 69
Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking
Zhao, M., Zhang, F., Zarnowski, R., Barns, K., Jones, R., Fossen, J., Sanchez, H., Rajski, S. R., Audhya, A., Bugni, T. S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145123 · Cited by 62
Self-citationCandida Arthritis: Analysis of 112 Pediatric and Adult Cases
Gamaletsou, M. N., Rammaert, B., Bueno, M. A., Sipsas, N. V., Moriyama, B., Kontoyiannis, D. P., Roilides, E., Zeller, V., Taj‐Aldeen, S. J., Miller, A. O., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv207 · Cited by 62
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 58
Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 56
Biofilm formation inCandida glabrata: What have we learnt from functional genomics approaches?
d’Enfert, C., & Janbon, G. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov111 · Cited by 58
Vila, T. V. M., Ishida, K., Seabra, S. H., & Rozental, S. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.022 · Cited by 52
Kumari, P., Arora, N., Chatrath, A., Gangwar, R., Pruthi, V., Poluri, K. M., & Prasad, R. (2019) · ACS Omega · doi:10.1021/acsomega.9b01482 · Cited by 51
Rossignol, T., Kelly, B. A., Dobson, C. B., & d’Enfert, C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00319-11 · Cited by 50
Biofilm Formation by Pseudallescheria/Scedosporium Species: A Comparative Study
Rollin‐Pinheiro, R., de Meirelles, J. V., Vila, T. V. M., Fonseca, B. B., Alves, V., Frasés, S., Rozental, S., & Barreto‐Bergter, E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01568 · Cited by 51
Development of a High-Throughput Candida albicans Biofilm Chip
Srinivasan, A., Uppuluri, P., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019036 · Cited by 47
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
Lewis, R. E., Viale, P., & Kontoyiannis, D. P. (2012) · Virulence · doi:10.4161/viru.20746 · Cited by 51
Sherry, L., Jose, A., Murray, C. A., Williams, C., Jones, B., Millington, O. R., Bagg, J., & Ramage, G. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00116 · Cited by 46
Role of the extracellular matrix in Candida biofilm antifungal resistance
Massey, J., Żarnowski, R., & Andes, D. R. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad059 · Cited by 47
Self-citationShinde, R. B., Raut, J. S., & Karuppayil, S. M. (2011) · Mycoscience · doi:10.1007/s10267-011-0155-y · Cited by 45
Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase
Bojsen, R. K., Regenberg, B., & Folkesson, A. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0305-4 · Cited by 47
Panariello, B. H. D., Klein, M. I., Pavarina, A. C., & Duarte, S. (2017) · Journal of Oral Microbiology · doi:10.1080/20002297.2017.1385372 · Cited by 47
Bojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42
Ramage, G., Zalewska, A., Cameron, D. A., Sherry, L., Murray, C. A., Finnegan, M. B., Loewy, Z. G., & Jagger, D. C. (2012) · Journal of Prosthodontics · doi:10.1111/j.1532-849x.2012.00865.x · Cited by 40
Lagree, K., & Mitchell, A. P. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0024-2016 · Cited by 41
New strategic insights into managing fungal biofilms
Borghi, E., Morace, G., Borgo, F., Rajendran, R., Sherry, L., Nile, C. J., & Ramage, G. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01077 · Cited by 41
Le, P. H., Linklater, D. P., Aburto‐Medina, A., MacLaughlin, S. A., Crawford, R. J., & Ivanova, E. P. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.02.006 · Cited by 39
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 44
Traven, A., Jänicke, A., Harrison, P. F., Swaminathan, A., Seemann, T., & Beilharz, T. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046243 · Cited by 36
Panariello, B. H. D., Klein, M. I., Mima, E. G. D. O., & Pavarina, A. C. (2018) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1476644 · Cited by 37
Watamoto, T., Samaranayake, L. P., Egusa, H., Yatani, H., & Seneviratne, C. J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030692-0 · Cited by 36
A quantitative real-time RT-PCR assay for mature C. albicans biofilms
Xie, Z., Thompson, A. K., Kashleva, H., & Dongari‐Bagtzoglou, A. I. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-93 · Cited by 37
Manfiolli, A. O., dos Reis, T. F., de Assis, L. J., de Castro, P. A., Silva, L. P., Hori, J. I., Walker, L. A., Munro, C. A., Rajendran, R., Ramage, G., et al. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.03.002 · Cited by 36
Shirazi, F., & Kontoyiannis, D. P. (2015) · Virulence · doi:10.1080/21505594.2015.1027479 · Cited by 35
Gupta, A. K., Talukder, M., Carviel, J., Cooper, E. A., & Piguet, V. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19217 · Cited by 39
Candida albicans Biofilms Are Generally Devoid of Persister Cells
Denega, I., d’Enfert, C., & Bachellier-Bassi, S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01979-18 · Cited by 32
Metadata
- Authors
- Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R.
- Affiliations
- University of Wisconsin–Madison (US)
- Departments of Medicine
- Corresponding author
- Andes, David R.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-08
- Volume
- 54
- Issue
- 8
- Pages
- 3505-3508
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2916329
- OpenAlex
- W2157946772
- Cited by
- 207
- References
- 22
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 14 · 2023: 16 · 2022: 11 · 2021: 10 · 2020: 17 · 2019: 13 · 2018: 11 · 2017: 17 · 2016: 16 · 2015: 19 · 2014: 14 · 2013: 10 · 2012: 9
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of Allergy and Infectious Diseases (R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, biofilm, FKS1, glucan synthase, echinocandin resistance, anidulafungin, amphotericin B, 5-fluorocytosine, triazole resistance, antifungal resistance, multidrug resistance, antifungal susceptibility
- MeSH terms
- Anidulafungin, Amphotericin B, Antifungal Agents, Candida albicans, Flucytosine, Fungal Proteins, Glucans, Glucosyltransferases, Humans, Microbial Sensitivity Tests, Polyenes, Pyrimidines, Biofilms, Drug Resistance, Fungal, Echinocandins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review